US President Donald Trump is convinced that the pharmaceutical company waited until after the election to hear the news that it had a vaccine. To harm him.
Biontech and Pfizer announced a good two weeks ago that they had developed a vaccine against the coronavirus.
Donald Trump believes pharmaceutical company Pfizer purposely waited to make the announcement. One wants to harm him.
If the news had been published before the US election, it would have had an impact on the election, the president said.
Pfizer had played “corrupt games”, said Donald Trump on Friday at a press conference in the White House. The president believes the pharmaceutical company deliberately waited until after the election to announce it had developed a vaccine. According to Trump, for two reasons: Firstly, because of Trump’s intention to lower drug prices, which he used to turn pharmaceutical companies against him. On the other hand, to harm him in the US elections.
“The big pharmaceutical companies have invested millions in vilifying me in the election campaign. The election campaign that, by the way, I won. You will find out in a while. Almost 74 million votes for me, ”said a president who has still not admitted his defeat.
Actually, according to Trump, the plan was for Pfizer to publish the data in October, i.e. before the election. “But they waited, waited and waited and then decided to publish the results just a few days after the election.” Presumably it would have had an impact on the election if Pfizer had made it public earlier, Trump said. “Maybe not. I’m sure the Democrats would have found these ballot papers somewhere. ” But it will not stop him from doing what is right for the American people.
Pfizer has denied an intentional delay, according to the New York Post.
Emergency approval applied for
In the meantime, Biontech and Pfizer, according to their own statements, have applied for emergency approval for their coronavirus vaccine with the US Food and Drug Administration. Pfizer confirmed this on Friday (local time) on Twitter. If the US authorities approve, they are now ready to start delivering the vaccine within a few hours, it said on Friday.
Pfizer has also already started filing applications with other health authorities around the world. Further applications for permits should follow, it was also said. If the active ingredient is approved, particularly vulnerable people in the USA could be vaccinated as early as mid to late December.